148 related articles for article (PubMed ID: 37266150)
1. QSAR and molecular docking studies on designing potent inhibitors of SARS-CoVs main protease.
Song F; Sun H; Ma X; Wang W; Luan M; Zhai H; Su G; Liu Y
Front Pharmacol; 2023; 14():1185004. PubMed ID: 37266150
[No Abstract] [Full Text] [Related]
2. QSAR study of unsymmetrical aromatic disulfides as potent avian SARS-CoV main protease inhibitors using quantum chemical descriptors and statistical methods.
Chtita S; Belhassan A; Bakhouch M; Taourati AI; Aouidate A; Belaidi S; Moutaabbid M; Belaaouad S; Bouachrine M; Lakhlifi T
Chemometr Intell Lab Syst; 2021 Mar; 210():104266. PubMed ID: 33558778
[No Abstract] [Full Text] [Related]
3. 3D,2D-QSAR study and docking of novel quinazolines as potential target drugs for osteosarcoma.
Lian Z; Sang C; Li N; Zhai H; Bai W
Front Pharmacol; 2023; 14():1124895. PubMed ID: 36895941
[No Abstract] [Full Text] [Related]
4. Discovery of unsymmetrical aromatic disulfides as novel inhibitors of SARS-CoV main protease: Chemical synthesis, biological evaluation, molecular docking and 3D-QSAR study.
Wang L; Bao BB; Song GQ; Chen C; Zhang XM; Lu W; Wang Z; Cai Y; Li S; Fu S; Song FH; Yang H; Wang JG
Eur J Med Chem; 2017 Sep; 137():450-461. PubMed ID: 28624700
[TBL] [Abstract][Full Text] [Related]
5. Design of Potent Inhibitors Targeting the Main Protease of SARS-CoV-2 Using QSAR Modeling, Molecular Docking, and Molecular Dynamics Simulations.
Oubahmane M; Hdoufane I; Delaite C; Sayede A; Cherqaoui D; El Allali A
Pharmaceuticals (Basel); 2023 Apr; 16(4):. PubMed ID: 37111365
[TBL] [Abstract][Full Text] [Related]
6. QSAR modeling and pharmacoinformatics of SARS coronavirus 3C-like protease inhibitors.
Ishola AA; Adedirin O; Joshi T; Chandra S
Comput Biol Med; 2021 Jul; 134():104483. PubMed ID: 34020129
[TBL] [Abstract][Full Text] [Related]
7. QSAR Study of Novel 1, 8-Naphthimide Derivatives Targeting Nuclear DNA.
Lian Z; Tai Y; Xia H; Zhai H
Anticancer Agents Med Chem; 2023; 23(6):726-733. PubMed ID: 36017845
[TBL] [Abstract][Full Text] [Related]
8. Unsymmetrical aromatic disulfides as SARS-CoV-2 Mpro inhibitors: Molecular docking, molecular dynamics, and ADME scoring investigations.
Chtita S; Belaidi S; Qais FA; Ouassaf M; AlMogren MM; Al-Zahrani AA; Bakhouch M; Belhassan A; Zaki H; Bouachrine M; Lakhlifi T
J King Saud Univ Sci; 2022 Oct; 34(7):102226. PubMed ID: 35875823
[TBL] [Abstract][Full Text] [Related]
9. 3D- and 2D-QSAR models' study and molecular docking of novel nitrogen-mustard compounds for osteosarcoma.
Zhuo W; Lian Z; Bai W; Chen Y; Xia H
Front Mol Biosci; 2023; 10():1164349. PubMed ID: 37065446
[No Abstract] [Full Text] [Related]
10. 2D, 3D-QSAR study and docking of vascular endothelial growth factor receptor 3 (VEGFR3) inhibitors for potential treatment of retinoblastoma.
Ren R; Gao L; Li G; Wang S; Zhao Y; Wang H; Liu J
Front Pharmacol; 2023; 14():1177282. PubMed ID: 37089961
[No Abstract] [Full Text] [Related]
11. QSAR, molecular docking, molecular dynamics and MM-GBSA approach for identification of prospective benzotriazole-based SARS-CoV 3CL protease inhibitors.
D'Souza S; Balaji S; K V P
J Biomol Struct Dyn; 2022; 40(24):14247-14261. PubMed ID: 34877897
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV M
Toropov AA; Toropova AP; Veselinović AM; Leszczynska D; Leszczynski J
J Biomol Struct Dyn; 2022 Feb; 40(2):780-786. PubMed ID: 32907512
[TBL] [Abstract][Full Text] [Related]
13.
Khan PM; Kumar V; Roy K
Comb Chem High Throughput Screen; 2021; 24(8):1281-1299. PubMed ID: 32928086
[TBL] [Abstract][Full Text] [Related]
14. QSAR Research of Novel Tetrandrine Derivatives against Human Hepatocellular Carcinoma.
Wang M; Qiu B; Wang W; Li X; Huo H
Anticancer Agents Med Chem; 2023; 23(19):2146-2153. PubMed ID: 37653634
[TBL] [Abstract][Full Text] [Related]
15. Discovery of genistein derivatives as potential SARS-CoV-2 main protease inhibitors by virtual screening, molecular dynamics simulations and ADMET analysis.
Liu J; Zhang L; Gao J; Zhang B; Liu X; Yang N; Liu X; Liu X; Cheng Y
Front Pharmacol; 2022; 13():961154. PubMed ID: 36091808
[No Abstract] [Full Text] [Related]
16. Computational modelling studies of some 1,3-thiazine derivatives as anti-influenza inhibitors targeting H1N1 neuraminidase via 2D-QSAR, 3D-QSAR, molecular docking, and ADMET predictions.
Abdullahi M; Uzairu A; Shallangwa GA; Mamza PA; Ibrahim MT
Beni Suef Univ J Basic Appl Sci; 2022; 11(1):104. PubMed ID: 36000144
[TBL] [Abstract][Full Text] [Related]
17. Quantitative structure-activity relationship and molecular docking studies on designing inhibitors of the perforin.
Song F; Cui L; Piao J; Liang H; Si H; Duan Y; Zhai H
Chem Biol Drug Des; 2017 Oct; 90(4):535-544. PubMed ID: 28296049
[TBL] [Abstract][Full Text] [Related]
18.
Maurya AK; Mishra N
J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
[TBL] [Abstract][Full Text] [Related]
19. Identification of lead compounds from large natural product library targeting 3C-like protease of SARS-CoV-2 using E-pharmacophore modelling, QSAR and molecular dynamics simulation.
Elekofehinti OO; Iwaloye O; Molehin OR; Famusiwa CD
In Silico Pharmacol; 2021; 9(1):49. PubMed ID: 34395160
[TBL] [Abstract][Full Text] [Related]
20. Quantitative Structure-Activity Relationship Study of Camptothecin Derivatives as Anticancer Drugs Using Molecular Descriptors.
Ahmadinejad N; Shafiei F
Comb Chem High Throughput Screen; 2019; 22(6):387-399. PubMed ID: 31284856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]